WMT
68
-2
INTC
35
4
MAS
46
3
LUV
45
3
SLG
37
6
UNH
42
6
HAL
40
11
AIG
38
5
FIS
43
5
TSCO
42
4
NWL
48
4
ADBE
50
3
HSY
32
3
GME
61
2
DGX
28
4
MO
47
6
IBM
53
2
ECL
54
5
CRM
65
6
AAP
26
5
WMT
68
-2
INTC
35
4
MAS
46
3
LUV
45
3
SLG
37
6
UNH
42
6
HAL
40
11
AIG
38
5
FIS
43
5
TSCO
42
4
NWL
48
4
ADBE
50
3
HSY
32
3
GME
61
2
DGX
28
4
MO
47
6
IBM
53
2
ECL
54
5
CRM
65
6
AAP
26
5
Financhill
Back

Editas Medicine Quote, Financials, Valuation and Earnings

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22

EDIT
Editas Medicine

Last Price:
$1.33
Seasonality Move:
-11.28%

7 Day Trial

ALL ACCESS PASS

$ 7

These 7 Stocks Will Be Magnificent in 2025

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.

Editas Medicine Price Quote

$1.33
+0.02 (+-0.75%)
(Updated: December 21, 2024 at 5:24 AM ET)

Editas Medicine Key Stats

Sell
22
Editas Medicine (EDIT) is a Sell
Day range:
$1.28 - $1.38
52-week range:
$1.28 - $11.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.74
P/B ratio:
0.62%
Volume:
4.2M
Avg. volume:
2.9M
1-year change:
-87.17%
Market cap:
$108.1M
Revenue:
$78.1M
EPS:
$-2.56

How Much Does Editas Medicine Make?

Data Unavailable

Is Editas Medicine Growing As A Company?

Data Unavailable

Editas Medicine Stock Price Performance

  • Did Editas Medicine Stock Go Up Last Month?
    Editas Medicine share price went down by -45.64% last month
  • Did EDIT's Share Price Rise Over The Last Year?
    EDIT share price fell by -87.17% over the past 1 year

What Is Editas Medicine 52-Week High & Low?

Editas Medicine Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Editas Medicine?

Data Unavailable

Is Editas Medicine Cash Flow Positive?

Data Unavailable

Editas Medicine Return On Invested Capital

Data Unavailable

Editas Medicine Earnings Date & Stock Price

Editas Medicine Competitors

  • Who Are Editas Medicine's Competitors?
    Below is a list of companies who compete with Editas Medicine or are related in some way:
    • Adverum Biotechnologies Inc (ADVM)
    • EyePoint Pharmaceuticals Inc (EYPT)
    • Ionis Pharmaceuticals Inc (IONS)
    • Regenxbio Inc (RGNX)
    • Cassava Sciences Inc (SAVA)

Editas Medicine Dividend Yield

Data Unavailable

Editas Medicine Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 2.53%
Revenue: -98.86% -98.43%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable